Wasp venom allergy immunotherapy - Allergopharma

Drug Profile

Wasp venom allergy immunotherapy - Allergopharma

Alternative Names: Wasp venom allergy vaccine - Allergopharma

Latest Information Update: 08 Jun 2015

Price : $50

At a glance

  • Originator Allergopharma
  • Class Allergens; Antiallergics; Hymenoptera allergy immunotherapies; Immunotherapies; Venoms
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Hypersensitivity

Most Recent Events

  • 08 Jun 2015 Discontinued - Phase-III for Hypersensitivity in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top